102 related articles for article (PubMed ID: 18097583)
1. Expression of hypoxia inducible factor-1alpha (HIF-1alpha) and glucose transporter-1 (GLUT-1) in ovarian adenocarcinomas: difference in hypoxic status depending on histological character.
Yasuda M; Miyazawa M; Fujita M; Kajiwara H; Iida T; Hirasawa T; Muramatsu T; Murakami M; Mikami M; Saitoh K; Shimizu M; Takekoshi S; Osamura RY
Oncol Rep; 2008 Jan; 19(1):111-6. PubMed ID: 18097583
[TBL] [Abstract][Full Text] [Related]
2. Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha/GLUT-1 expression.
Iida T; Yasuda M; Miyazawa M; Fujita M; Osamura RY; Hirasawa T; Muramatsu T; Murakami M; Saito K; Mikami M
Arch Gynecol Obstet; 2008 Jun; 277(6):539-46. PubMed ID: 18026974
[TBL] [Abstract][Full Text] [Related]
3. Association of hypoxia-inducible factor-1 expression with histology in epithelial ovarian tumors: a quantitative analysis of HIF-1.
Miyazawa M; Yasuda M; Fujita M; Hirasawa T; Kajiwara H; Hirabayashi K; Ogane N; Shimizu M; Asanuma H; Murakami M; Takekoshi S; Mikami M; Osamura RY
Arch Gynecol Obstet; 2009 Jun; 279(6):789-96. PubMed ID: 18936945
[TBL] [Abstract][Full Text] [Related]
4. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
Ozbudak IH; Karaveli S; Simsek T; Erdogan G; Pestereli E
Gynecol Oncol; 2008 Mar; 108(3):603-8. PubMed ID: 18191183
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma.
Miyazawa M; Yasuda M; Fujita M; Kajiwara H; Hirabayashi K; Takekoshi S; Hirasawa T; Murakami M; Ogane N; Kiguchi K; Ishiwata I; Mikami M; Osamura RY
Pathol Int; 2009 Jan; 59(1):19-27. PubMed ID: 19121088
[TBL] [Abstract][Full Text] [Related]
6. [Relation between the expression of hypoxia inducible factor-1alpha and angiogenesis in ovarian cancer using tissue microarray].
Luo J; Peng ZL; Yang KX; Wang H; Yang H; Dong DD; Yao XY
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):38-41. PubMed ID: 15774091
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia inducible factors 1alpha and 2alpha are associated with VEGF expression and angiogenesis in gallbladder carcinomas.
Giatromanolaki A; Sivridis E; Simopoulos C; Polychronidis A; Gatter KC; Harris AL; Koukourakis MI
J Surg Oncol; 2006 Sep; 94(3):242-7. PubMed ID: 16900513
[TBL] [Abstract][Full Text] [Related]
8. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C
Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma.
Horrée N; Gort EH; van der Groep P; Heintz AP; Vooijs M; van Diest PJ
J Pathol; 2008 Jan; 214(1):38-45. PubMed ID: 17985331
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of regulation of leptin expression in human lung adenocarcinoma cells by hypoxia inducible factor-1alpha: a preliminary study].
Zhang YB; Fang M; He FL; Hua TF; Hu BD; Zhao H; Liu RY
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2848-53. PubMed ID: 19080496
[TBL] [Abstract][Full Text] [Related]
11. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
Zhu DM; Li DC; Zhang ZX; Zhang XY
Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma.
Lee S; Garner EI; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2007 Aug; 106(2):311-7. PubMed ID: 17532031
[TBL] [Abstract][Full Text] [Related]
13. The expression and significance of HIF-1alpha and GLUT-3 in glioma.
Liu Y; Li YM; Tian RF; Liu WP; Fei Z; Long QF; Wang XA; Zhang X
Brain Res; 2009 Dec; 1304():149-54. PubMed ID: 19782666
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
15. [Tissue microarray and in situ hybridization study on hypoxia inducible factor 1alpha mRNA expression in epithelial ovarian tumor].
Luo J; Peng ZL; Wang H; Cheng YF; Yang KX; Xie L; Qian XL; Zou Y
Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):168-70. PubMed ID: 12795846
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
[TBL] [Abstract][Full Text] [Related]
17. The human HIF (hypoxia-inducible factor)-3alpha gene is a HIF-1 target gene and may modulate hypoxic gene induction.
Tanaka T; Wiesener M; Bernhardt W; Eckardt KU; Warnecke C
Biochem J; 2009 Oct; 424(1):143-51. PubMed ID: 19694616
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma.
Ishikawa T; Nakashiro K; Klosek SK; Goda H; Hara S; Uchida D; Hamakawa H
Oncol Rep; 2009 Mar; 21(3):707-12. PubMed ID: 19212630
[TBL] [Abstract][Full Text] [Related]
19. Role of hypoxia-inducible factor-1alpha in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes.
Ahn JK; Koh EM; Cha HS; Lee YS; Kim J; Bae EK; Ahn KS
Rheumatology (Oxford); 2008 Jun; 47(6):834-9. PubMed ID: 18400834
[TBL] [Abstract][Full Text] [Related]
20. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
Lidgren A; Bergh A; Grankvist K; Rasmuson T; Ljungberg B
BJU Int; 2008 Feb; 101(4):480-4. PubMed ID: 17922867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]